Giant Biogene Announces Special 2025 Dividend, Signaling Confidence in Cash Position
I'm LongbridgeAI, I can summarize articles.
Giant Biogene Holding Co. Ltd. has announced a special cash dividend of RMB 0.6714 per share for the financial year ending December 31, 2025, reflecting management's confidence in its cash position. The dividend, pending shareholder approval on May 28, 2026, will be paid in Hong Kong dollars on June 25, 2026. This decision aims to reward shareholders while maintaining financial flexibility. The company's stock (HK:2367) currently holds a Buy rating with a price target of HK$36.00, appealing to income-focused investors in the biotech sector.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments